Clinical pharmacology, drug-drug interactions and safety of pazopanib: a review.
about
Pharmacokinetic drug evaluation of pazopanib for the treatment of uterine leiomyosarcomas.Pharmacodynamic and Pharmacokinetic Markers For Anti-angiogenic Cancer Therapy: Implications for Dosing and Selection of Patients.Development and validation of a micellar liquid chromatographic method to determine three antitumorals in plasma.
P2860
Clinical pharmacology, drug-drug interactions and safety of pazopanib: a review.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Clinical pharmacology, drug-drug interactions and safety of pazopanib: a review.
@en
type
label
Clinical pharmacology, drug-drug interactions and safety of pazopanib: a review.
@en
prefLabel
Clinical pharmacology, drug-drug interactions and safety of pazopanib: a review.
@en
P2093
P2860
P50
P1476
Clinical pharmacology, drug-drug interactions and safety of pazopanib: a review.
@en
P2093
Audrey Thomas-Schoemann
Benoit Blanchet
François Goldwasser
Jennifer Arrondeau
Jérôme Alexandre
Olivier Huillard
Pascaline Boudou-Rouquette
P2860
P304
P356
10.1080/17425255.2016.1225038
P407
P577
2016-08-24T00:00:00Z